Cholelithiasis in Infants: Risk Factors, Management, and the Role of Ursodeoxycholic Acid

Cholelithiasis in Infants: Risk Factors, Management, and the Role of Ursodeoxycholic Acid

Background: Cholelithiasis is a rare disease in infants, and there is limited data on its risk factors and management. Objectives: To evaluate the risk factors, management, and response to medical treatment of cholelithiasis in infants. Methods: Infants diagnosed with cholelithiasis by ultrasound be...

Full description

Saved in:

Bibliographic Details
Main Authors:	Sevim Çakar, Gülin Eren, Cahit Barış Erdur, Mehmet Önder, Şafak Pelek, Sedef Alpdoğan, Duygu Demirtaş, Çiğdem Ömür Ecevit, Özlem Bekem
Format:	Article
Language:	English
Published:	MDPI AG 2024-12-01
Series:	Children
Subjects:	children gallstones infant ursodeoxycholic acid
Online Access:	https://www.mdpi.com/2227-9067/11/12/1553
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Efficacy of ursodeoxycholic acid in reducing the necessity of cholecystectomy due to pre-existing and subsequently formed gallstones in patients who underwent laparoscopic sleeve gastrectomy
by: Muhammed Taha Demirpolat, et al.
Published: (2025-01-01)

STATINS AND URSODEOXYCHOLIC ACID: COOPERATION OR NEUTRALITY?
by: I. N. Grigorieva, et al.
Published: (2016-01-01)

Management of Asymptomatic Cholelithiasis
by: Chiranjiva Khandelwal, et al.
Published: (2025-01-01)

Ursodeoxycholic acid and hepatic diseases
by: G. V. Volynets, et al.
Published: (2021-06-01)

Ursodeoxycholic acid therapy in children with cholestatic liver disease
by: Gönül Dinler, et al.
Published: (1999-01-01)

Ursodeoxycholic acid for the treatment of hepatic sarcoid: A pre-post pilot study
by: Ethan Weinberg, et al.
Published: (2024-07-01)

Effect of Ursodeoxycholic Acid Alone Verses Ursodeoxycholic Acid and Rifampicin in Obstetric Cholestasis
by: Ayesha Amjad, et al.
Published: (2025-07-01)

Application of ursodeoxycholic acid at non-alcoholic and alcohol-induced steatohepatitis
by: Ye. A. Fedos’ina, et al.
Published: (2010-06-01)

Studies on the Synthesis Process of Plant-Derived Ursodeoxycholic Acid Intermediates
by: Shaoxiong Jing, et al.
Published: (2025-03-01)

Clinical experience with ursodeoxycholic acid (Urdoxa) in complex therapy of chronic viral hepatitis
by: E. V. Esaulenko, et al.
Published: (2014-09-01)

The Impact of Ursodeoxycholic Acid on Indirect Hyperbilirubinemia in Infants Treated with Photo-therapy: A Single-Blind Randomized Clinical Trial
by: Mohammad Sobhani Shahmirzadi, et al.
Published: (2024-10-01)

Evaluating the effects of different doses of ursodeoxycholic acid on neonatal jaundice
by: Manizheh Mostafa Gharehbaghi, et al.
Published: (2020-06-01)

Risk Factor of Dietary Habit with Cholelithiasis
by: Annora Zerlina Lysandra, et al.
Published: (2022-06-01)

Protective Effect of Ursodeoxycholic Acid in Experimental Endometriosis Induced Rat Model
by: Ali Seven, et al.
Published: (2023-11-01)

The impact of the ursodeoxycholic acid as monotherapy and in the combination with the lactulose on the biochemical blood tests values of the nonalcoholic steatohepatitis patients
by: I. V. Mayev, et al.
Published: (2013-03-01)

Host‐Microbial Cometabolite Ursodeoxycholic Acid Protects Against Poststroke Cognitive Impairment
by: Xuxuan Gao, et al.
Published: (2025-05-01)

Rationale, completeness and quality of evidence for the use of ursodeoxycholic acid in neonatal hyperbilirubinemia
by: Olesya V. Zakharova
Published: (2024-05-01)

Comparative chemoreactomic analysis of ornithine aspartate, S-ademethionine and ursodeoxycholic acid
by: I. Yu. Torshin, et al.
Published: (2022-01-01)

Gallstones after bariatric surgery: mechanisms and prophylaxis
by: Shenhao Chen, et al.
Published: (2025-03-01)

The effects of ursodeoxycholic acid on cardiometabolic risk factors: a systematic review and meta-analysis of randomized controlled trials
by: Elaheh Rashidbeygi, et al.
Published: (2025-02-01)

Cholelithiasis in Patients with Sickle Cell Disease and Sickle/Beta-Thalassemia in Akre City, Kurdistan Region of Iraq
by: Esraa Hasan Abdullah, et al.
Published: (2024-03-01)

Efficiency of ursodeoxycholic acid in the frameworks of minimization of hepatotoxic potential of eradication therapy of Helicobacter pylori infection
by: D. N. Andreev, et al.
Published: (2021-06-01)

Non-alcoholic fatty liver disease: a heterogeneous phenotype. Pleiotropic effects of ursodeoxycholic acid
by: E. A. Ljaljukova
Published: (2023-08-01)

Double-negative T cells in combination with ursodeoxycholic acid ameliorates immune-mediated cholangitis in mice
by: Chunpan Zhang, et al.
Published: (2025-04-01)

Combinatorial Effects of Ursodeoxycholic Acid and Antibiotic in Combating <i>Staphylococcus aureus</i> Biofilm: The Roles of ROS and Virulence Factors
by: Anuradha Tyagi, et al.
Published: (2024-09-01)

Treatment of autoimmune thrombocytopenia in a case of chronic hepatitis C with ursodeoxycholic acid
by: Hasan Naz, et al.
Published: (2009-09-01)

Results of oral litholysis with ursodeoxycholic acid in a patient with cholesterol cholecystolithiasis
by: Pavel V. Seliverstov, et al.
Published: (2024-12-01)

Anticarcinogenic effects of ursodeoxycholic acid in pancreatic adenocarcinoma cell models
by: Patrik Kovács, et al.
Published: (2024-12-01)

Ursodeoxycholic acid relieves clinical severity of COVID-19 in patients with chronic liver diseases
by: Tiantian Hu, et al.
Published: (2025-02-01)

The role of intestinal microflora in the development of cholelithiasis (literature review)
by: N. A. Hohlacheva, et al.
Published: (2020-01-01)

Ursodeoxycholic acid preparations in the complex treatment of non-alcoholic fatty liver disease and diabetes mellitus
by: U. A. Khalilova, et al.
Published: (2023-06-01)

What is the impact of previous cholelithiasis on sialolithiasis: A systematic review and meta-analysis
by: Hamed Mortazavi, et al.
Published: (2024-01-01)

Efficiency and safety of application of combined scheme with ursodeoxycholic acid and mebeverin preparations in patients with metabolic syndrome
by: Yu. P. Uspensky, et al.
Published: (2021-06-01)

The effectiveness of combining ursodeoxycholic acid with vitamin D in treating patients with primary biliary cholangitis and its impact on hepatic fibrosis: a randomized trial
by: Yilihamu Abulitifu, et al.
Published: (2025-07-01)

Stage I cholelithiasis. Approaches to diagnosis and treatment. Results of the Machaon study
by: Sabir N. Mekhtiev, et al.
Published: (2025-01-01)

Prevalence of Cholelithiasis and Associated Factors of Gallstone Formation after Laparoscopic Sleeve Gastrectomy in the Gastroenterology and Hepatology Teaching Hospital-Baghdad
by: Abdulrahman M. Mohammed, et al.
Published: (2024-12-01)

How to avoid statin hepatotoxicity in patients with obesity and liver disease? Focus on the combination of ursodeoxycholic acid and atorvastatin
by: O. N. Korneeva, et al.
Published: (2012-12-01)

Dietary ursodeoxycholic acid supplementation enhanced nonspecific immunity, antioxidant capacity, and anti-inflammatory-related gene expression in juvenile large yellow croaker (Larimichthys crocea)
by: Aijun Zhu, et al.
Published: (2025-04-01)

A Study of Gallstones Disease incidence in Babylon's Province population
by: Mahmoud Al-Mukhtar
Published: (2013-07-01)

The Effect of Ursodeoxycholic Acid (UDCA) on Serum Expression of miR-34a and miR-506 in Patients with Chronic Cholestatic Liver Diseases
by: Eliza Cielica, et al.
Published: (2025-07-01)